Organic net sales grew 4.6% and order intake rose 6.2% year-over-year, with margin gains driven by a tariff refund and operational improvements. Acute Care Therapies led growth, recurring revenue share increased, and leverage remained low. 2026 organic sales are expected to rise 3-5%.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.